Hunan Warrant Pharmaceutical Co.,Ltd (SHA:688799)
China
· Delayed Price · Currency is CNY 57.64
-0.57 (-0.98%)
Apr 30, 2026, 9:44 AM CST
SHA:688799 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 213.76 | 228.1 | 164.32 | 211.32 | 182.8 | 160.76 | Upgrade
|
| Depreciation & Amortization | 71.05 | 71.05 | 68.9 | 61.02 | 48.79 | 34.22 | Upgrade
|
| Other Amortization | 5.78 | 5.78 | 3.21 | 1.3 | 0.53 | 0.06 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0 | 0 | - | -0 | - | 0.18 | Upgrade
|
| Asset Writedown & Restructuring Costs | 8.86 | 8.86 | 0.03 | 0.48 | 0.89 | 0.21 | Upgrade
|
| Loss (Gain) From Sale of Investments | -84.46 | -84.46 | 24.16 | -3.58 | -7.98 | -1.71 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | 0.31 | 1.47 | 2.23 | 1.31 | Upgrade
|
| Other Operating Activities | 48.38 | 2.51 | -30.16 | -19.19 | -5.34 | 3.08 | Upgrade
|
| Change in Accounts Receivable | -56.44 | -56.44 | -118.65 | -51.33 | 11.32 | -31.56 | Upgrade
|
| Change in Inventory | 11.07 | 11.07 | -55.23 | -31 | -43.25 | -115.58 | Upgrade
|
| Change in Accounts Payable | 60.41 | 60.41 | 106.39 | 50.84 | -34.77 | 66.49 | Upgrade
|
| Change in Other Net Operating Assets | 51.96 | 51.96 | - | - | - | - | Upgrade
|
| Operating Cash Flow | 331.74 | 300.2 | 142.23 | 214.44 | 155.65 | 114.72 | Upgrade
|
| Operating Cash Flow Growth | 164.75% | 111.07% | -33.68% | 37.78% | 35.67% | 9.62% | Upgrade
|
| Capital Expenditures | -609.76 | -520.32 | -233.87 | -105.76 | -131.85 | -92.1 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.07 | 0.07 | 0.02 | 0.05 | 0.12 | 0.13 | Upgrade
|
| Cash Acquisitions | - | - | - | - | 0.07 | - | Upgrade
|
| Divestitures | 5.97 | 5.97 | - | - | - | - | Upgrade
|
| Investment in Securities | -149.23 | -106.47 | -125.21 | 134.47 | -111.7 | -429.6 | Upgrade
|
| Other Investing Activities | 9.8 | 11.57 | 0.24 | 10.37 | 12.74 | 4.26 | Upgrade
|
| Investing Cash Flow | -743.15 | -609.17 | -358.82 | 39.12 | -230.62 | -517.3 | Upgrade
|
| Long-Term Debt Issued | - | 384 | 100.61 | 17.11 | - | - | Upgrade
|
| Total Debt Issued | 537.86 | 384 | 100.61 | 17.11 | - | - | Upgrade
|
| Net Debt Issued (Repaid) | 537.86 | 384 | 100.61 | 17.11 | - | - | Upgrade
|
| Issuance of Common Stock | 14.97 | 14.97 | - | - | - | 674.02 | Upgrade
|
| Common Dividends Paid | -66.11 | -62.96 | -86.35 | -84.44 | -65.66 | - | Upgrade
|
| Other Financing Activities | -9.97 | - | - | 9.87 | -10.71 | -18.36 | Upgrade
|
| Financing Cash Flow | 476.75 | 336.01 | 14.26 | -57.47 | -76.37 | 655.65 | Upgrade
|
| Foreign Exchange Rate Adjustments | -1.59 | -0.99 | 0.42 | 0.01 | 0.53 | -0.03 | Upgrade
|
| Net Cash Flow | 63.75 | 26.04 | -201.91 | 196.11 | -150.82 | 253.04 | Upgrade
|
| Free Cash Flow | -278.02 | -220.12 | -91.65 | 108.68 | 23.8 | 22.63 | Upgrade
|
| Free Cash Flow Growth | - | - | - | 356.70% | 5.18% | -55.56% | Upgrade
|
| Free Cash Flow Margin | -18.63% | -14.63% | -6.49% | 7.58% | 1.84% | 1.97% | Upgrade
|
| Free Cash Flow Per Share | -2.06 | -1.64 | -0.70 | 0.83 | 0.18 | 0.20 | Upgrade
|
| Cash Income Tax Paid | 154.8 | 142.82 | 198.54 | 192.83 | 152.18 | 132.83 | Upgrade
|
| Levered Free Cash Flow | -213.18 | -531.53 | -166.29 | 69.89 | -40.72 | -33.38 | Upgrade
|
| Unlevered Free Cash Flow | -213.18 | -531.53 | -166.28 | 69.89 | -40.72 | -33.38 | Upgrade
|
| Change in Working Capital | 68.36 | 68.36 | -88.55 | -38.36 | -66.28 | -83.39 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.